CG50
Amberlite™ CG50
macroreticular
Synonym(s):
Amberlite™ Weakly Acidic Cation Exchanger, Hydrogen form
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
form
macroreticular
Quality Level
parameter
≤120 °C
technique(s)
activity assay: suitable
matrix
4% cross-linked methacrylate
matrix activation
carboxylic acid
particle size
100-200 mesh (wet)
pH
5-14(effective)
capacity
10.0 meq/g, 3.5 meq/mL
General description
Amberlite™ is an ion exchange resin, which is macroporous weak acid cation exchange resin. The matrix is a polyacrylic with a particle diameter of 500 − 750 μm.
Application
The Amberlite weakly acidic cation exchanger is in the hydrogen form and is used in protein chromatography, ion exchange chromatography and cation exchange media.
Amberlite™ Weakly Acidic Cation Exchanger, Hydrogen form has been used in purification of thiamine from crude food extracts and bovine lactoperoxidase enzyme.
Legal Information
Amberlite is a trademark of DuPont de Nemours, Inc.
Storage Class
11 - Combustible Solids
wgk
WGK 2
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
dust mask type N95 (US), Eyeshields, Gloves
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Kinetic parameters of thiamine degradation in NASA spaceflight foods determined by the endpoints method for long-term storage
Goulette TR, et al.
Food Chemistry, 302, 125365-125365 (2020)
Mohammad Said Hosseini et al.
Analytical sciences : the international journal of the Japan Society for Analytical Chemistry, 19(11), 1505-1508 (2003-12-03)
A method for the trace amount determination of Tl(I), via its preconcentration, is proposed. The method is based on the reaction of iodide, Tl(I) and Rhodamine B in a weakly acidic medium. In this process an ion-associated complex is formed
Martin Raithel et al.
BMC gastroenterology, 15, 41-41 (2015-04-19)
Patients with gastrointestinal food allergy are characterised by increased production of mast cell derived mediators upon allergen contact and present often with unspecific symptoms. The aim of this study was to evaluate urinary histamine and methylhistamine excretion in patients with